Diagnosing heart failure
Until the late 1990s, getting a definitive heart failure diagnosis was difficult. BHF-funded research helped change that.
Until the late 1990s, getting a definitive heart failure diagnosis was difficult. BHF-funded research helped change that.
Learn about the breakthroughs BHF-funded researchers have made in medicines to treat heart failure.
We’ve been developing and testing new ways of delivering care for heart failure patients, to improve the lives of people with heart failure.
Heart failure cannot be cured. To change that, we’ve been funding research into ways to repair or regrow damaged heart tissue.
Our work has helped improve heart transplants and make more organs available.
In the past, severe thalassemia (an inherited blood disorder) was often fatal by early adulthood. BHF-funded research has changed that.
Our research has increased the survival and quality of life of people leaving with pulmonary hypertension.
BHF-funded researchers have identified genes responsible for this life-threatening condition and are developing new treatments.
We’re funding research to develop AI tools to better diagnose pulmonary hypertension and to predict how the condition will progress.
Over the past 6 decades, BHF has supported important breakthroughs in our journey to power science to save lives.
BHF is the biggest independent funder of heart and circulatory research in the UK. Discover the impact of our research and see how we save lives.
We've made incredible progress tackling cardiovascular diseases, thanks to the work of BHF researchers. Learn more about the research we’re funding.